Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
Open Access
- 23 July 2022
- journal article
- review article
- Published by Taylor & Francis in Degenerative Neurological and Neuromuscular Disease
- Vol. ume 12, 97-109
Abstract
The effective management of OFF episodes remains an important unmet need for patients with Parkinson’s disease (PD) who develop motor complications with long-term levodopa therapy. Istradefylline is a selective adenosine A2A receptor antagonist for the treatment of patients with PD experiencing OFF episodes while on levodopa/decarboxylase inhibitor. Originally approved in Japan, istradefylline was recently approved in the USA. In this article, we provide a specific review of the four clinical studies that the FDA included in the approval of istradefylline in the USA, and discuss common clinical scenarios, based on our experience, where treatment with istradefylline may benefit patients experiencing motor fluctuations.Keywords
This publication has 74 references indexed in Scilit:
- Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's diseaseMovement Disorders, 2011
- Fatigue in Parkinson's disease: Prevalence and associated factorsMovement Disorders, 2010
- Clinical efficacy of istradefylline (KW‐6002) in Parkinson's disease: A randomized, controlled studyMovement Disorders, 2010
- Adenosine A2A receptors and basal ganglia physiologyProgress in Neurobiology, 2007
- Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcomeMovement Disorders, 2007
- The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerationsExpert Opinion on Pharmacotherapy, 2006
- Effect of dopamine agonists on fatigue and somnolence in Parkinson's diseaseMovement Disorders, 2006
- Suboptimal medication adherence in Parkinson's diseaseMovement Disorders, 2005
- Orthostatic Hypotension in Patients with Parkinson??s DiseaseDrugs & Aging, 2001
- Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic studySynapse, 1997